|
HY-P0097A-1mL
|
MedChemexpress LLC
|
Nonapeptide-1 (acetate salt) [CAS ] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P0097-10mg
|
MedChemexpress LLC
|
Nonapeptide-1 [CAS 158563-45-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-P0097-25mg
|
MedChemexpress LLC
|
Nonapeptide-1 [CAS 158563-45-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-P0097-5mg
|
MedChemexpress LLC
|
Nonapeptide-1 [CAS 158563-45-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-141449-10mg
|
MedChemexpress LLC
|
NRX-103094 [CAS 2763260-36-0]
|
|
Cancer-programmed cell death
|
|
|
HY-141449-100mg
|
MedChemexpress LLC
|
NRX-103094 [CAS 2763260-36-0]
|
|
Cancer-programmed cell death
|
|
|
HY-141449-25mg
|
MedChemexpress LLC
|
NRX-103094 [CAS 2763260-36-0]
|
|
Cancer-programmed cell death
|
|
|
HY-141449-5mg
|
MedChemexpress LLC
|
NRX-103094 [CAS 2763260-36-0]
|
|
Cancer-programmed cell death
|
|
|
HY-141449-50mg
|
MedChemexpress LLC
|
NRX-103094 [CAS 2763260-36-0]
|
|
Cancer-programmed cell death
|
|
|
HY-141450-10mg
|
MedChemexpress LLC
|
NRX-103095 [CAS 2763260-38-2]
|
|
Cancer-programmed cell death
|
|
|
HY-141450-100mg
|
MedChemexpress LLC
|
NRX-103095 [CAS 2763260-38-2]
|
|
Cancer-programmed cell death
|
|
|
HY-141450-25mg
|
MedChemexpress LLC
|
NRX-103095 [CAS 2763260-38-2]
|
|
Cancer-programmed cell death
|
|
|
HY-141450-5mg
|
MedChemexpress LLC
|
NRX-103095 [CAS 2763260-38-2]
|
|
Cancer-programmed cell death
|
|
|
HY-141450-50mg
|
MedChemexpress LLC
|
NRX-103095 [CAS 2763260-38-2]
|
|
Cancer-programmed cell death
|
|
|
HY-141450-1mL
|
MedChemexpress LLC
|
NRX-103095 [CAS 2763260-38-2] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-111836-10mg
|
MedChemexpress LLC
|
NRX-252114 [CAS 2763260-39-3]
|
|
Cancer-programmed cell death
|
|
|
HY-111836-100mg
|
MedChemexpress LLC
|
NRX-252114 [CAS 2763260-39-3]
|
|
Cancer-programmed cell death
|
|
|
HY-111836-25mg
|
MedChemexpress LLC
|
NRX-252114 [CAS 2763260-39-3]
|
|
Cancer-programmed cell death
|
|
|
HY-111836-5mg
|
MedChemexpress LLC
|
NRX-252114 [CAS 2763260-39-3]
|
|
Cancer-programmed cell death
|
|
|
HY-111836-50mg
|
MedChemexpress LLC
|
NRX-252114 [CAS 2763260-39-3]
|
|
Cancer-programmed cell death
|
|
|
HY-141448-10mg
|
MedChemexpress LLC
|
NRX-2663 [CAS 2763260-34-8]
|
|
Cancer-programmed cell death
|
|
|
HY-141448-100mg
|
MedChemexpress LLC
|
NRX-2663 [CAS 2763260-34-8]
|
|
Cancer-programmed cell death
|
|
|
HY-141448-25mg
|
MedChemexpress LLC
|
NRX-2663 [CAS 2763260-34-8]
|
|
Cancer-programmed cell death
|
|
|
HY-141448-5mg
|
MedChemexpress LLC
|
NRX-2663 [CAS 2763260-34-8]
|
|
Cancer-programmed cell death
|
|
|
HY-141448-50mg
|
MedChemexpress LLC
|
NRX-2663 [CAS 2763260-34-8]
|
|
Cancer-programmed cell death
|
|
